Decera Clinical Education Infectious Disease Podcast

Closing Gaps in STI Care Through Molecular Point-of-Care Testing

Episode Summary

Molecular point-of-care testing has the potential to substantially mitigate the impact of sexually transmitted infections (STIs) on personal and public health. Listen in as Jeffrey D. Klausner, MD, MPH, explores how proper use of rapid point-of-care testing could also hold the key to limiting development of antimicrobial resistance.

Episode Notes

Molecular point-of-care testing has the potential to substantially mitigate the impact of sexually transmitted infections (STIs) on personal and public health. Listen in to learn how it may even limit the development of antimicrobial resistance. Topics covered include:

• CDC and US Preventive Services Task Force STI screening recommendations
• Whether or not laboratory-based STI tests contribute to increasing antibiotic resistance
• Role of point-of-care testing and strategies for implementation

Presenter:
Jeffrey D. Klausner, MD, MPH
Clinical Professor of Medicine
Population and Public Health Sciences Lead
Infectious Diseases Epidemiology and Applies Studies (I.D.E.A.S.) Initiative
Keck School of Medicine of the University of Southern California
Los Angeles, California

Link to full program:
https://bit.ly/4nS7rYE

Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify.